The study is a comparative study between intravenous Lignocaine with intravenous Lignocaine and magnesium sulphate combination for laparoscopic Nephrectomy to evaluate the effectiveness of pain management during post operative in 24 hours

Comparison of intravenous Lignocaine with intravenous Lignocaine and Magnesium sulphate combination for laparoscopic Nephrectomy

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2022/03/041115

Enrollment

100

Registered

2022-03-15

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Elective laparoscopic Nephrectomy

Exclusion criteria

Exclusion criteria: 1 Refused consent, 2 Allergic to local anaesthetic agent and opiods 3 on long term analgesic to chronic pain 4 Impaired liver function 5 Has a history of arrhythmia 6 Viral marker reactive 7 Covid 19 positive.

Design outcomes

Primary

Measure	Time frame
quality of recovery scoreTimepoint: at 24 hr postoperative period	—

Secondary

Measure	Time frame
hemodynamics every 30 min after starting infusion. NRS pain score total opioid consumptionTimepoint: 24 hrs postoperative period	—

Countries

India

Contacts

Public ContactSwati

Indira Gandhi Institute of Medical Science,Patna,Bihar.

nokzei22@yahoo.com8731955881

Outcome results